Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MBP8298 in Secondary Progressive Multiple Sclerosis
NCT00468611Phase 3Terminated
- Sponsor
- BioMS Medical Corp.
- Start
- Jun 2007
- Primary completion
- Jul 2009
- Modality
- Peptides
01
Overview
A Phase 3 trial of dirucotide in secondary-progressive multiple sclerosis (SPMS), sponsored by BioMS Medical Corp.. Started Jun 2007; status: terminated.
02
Drugs
dirucotide
03
Conditions
secondary-progressive multiple sclerosis (SPMS)
Beyond the preview
Go deeper on NCT00468611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00468611.